Case study

Scaling oncology navigation for 30MM annual visitors

Led digital product strategy for an oncology information and patient-engagement platform serving 30MM annual visitors. Translated clinical protocols into plain-language navigation flows patients and families could follow without a nurse on the phone.

2019–2021

Director of Digital Products & Strategy. Led relaunch and product strategy for an oncology information, navigation, and patient-engagement platform. Directed $2M in software development execution.

CancerCompass archival homepage screenshot
CancerCompass archival public surface — the oncology navigation platform serving 30MM annual visitors.

Led digital product strategy for an oncology information and patient-engagement platform serving 30MM annual visitors. Translated clinical protocols into plain-language navigation flows patients and families could follow without a nurse on the phone.

An oncology information platform with 30MM annual visitors needed to translate clinical protocols into actionable steps for patients and families navigating cancer care — without requiring a nurse on the phone for every interaction.

An oncology information platform with 30MM annual visitors needed to translate clinical protocols into actionable steps for patients and families navigating cancer care — without requiring a nurse on the phone for every interaction.

Led relaunch with plain-language navigation flows, feedback loops with nursing teams to tune triage rules, and reliability reviews so content updates stayed aligned with clinical oversight.

Directed product strategy and $2M in software development execution. Wrote the Director of Development job description and defined the tech-stack architecture for the platform's rebuild. Built feedback loops with nursing teams to continuously tune triage rules and reduce avoidable escalations.

Reduced bounce rate by 25% and increased chat conversions by 267% through interface and analytics updates. Directed $2M in software development across core platforms.

1 CancerCompass was owned and operated by Cancer Treatment Centers of America Marketplace, LLC.

Federal filing naming the employer entity and describing the product: physician matching, patient engagement with chat and video, oncology information.

USPTO trademark 90330500

2 CTCA was acquired by City of Hope in 2021.

Public company context for the acquisition.

Axios
  • Clinical accuracy requirements for oncology information.
  • Patient-facing content requiring clinical oversight and reliability reviews.
  • Platform rebuild requiring new tech-stack architecture and team.
  • Plain-language navigation flows translating clinical protocols.
  • Feedback loops with nursing teams to tune triage rules.
  • Reliability reviews for content updates with clinical oversight.
  • Interface and analytics updates that reduced bounce rate and increased conversions.
  • Reduced bounce rate by 25% through interface and analytics updates.
  • Increased chat conversions by 267% through interface and analytics updates.
  • Directed $2M in software development execution across core platforms.
  • Translated clinical protocols into plain-language steps patients and families could follow at scale.
  • Director of Development job description and tech-stack architecture for platform rebuild.
  • Navigation flow designs translating oncology protocols into patient-actionable steps.
  • Triage tuning protocol with nursing team feedback loops.

← Back to portfolio